US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VictoryShares Pioneer Asset-Based Income ETF

24.98

0.0000

Volume:90.00

Turnover:2.25K

Market Cap:55.57M

PE:- -

High:24.98

Open:24.98

Low:24.98

Close:24.98

52wk High:25.27

52wk Low:24.89

Shares:2.23M

Float Shares:2.23M

Volume Ratio:1.78

T/O Rate:0.00%

Dividend:0.38

Dividend Rate:1.51%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Assembly Biosciences’ ABI-6250 Study: A Potential Game-Changer in Hepatitis Treatment

AIA: "Softness persists at architecture firms" in September

Calculated Risk

Promising Phase 1b Results for ABI-5366 Drive Buy Rating for Assembly Biosciences

Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ABI"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABI\",,,,,undefined,":{"symbol":"ABI","market":"US","secType":"STK","nameCN":"VictoryShares Pioneer Asset-Based Income ETF","latestPrice":24.975,"timestamp":1761595200000,"preClose":24.975,"halted":0,"volume":90,"delay":0,"floatShares":2225000,"shares":2225000,"eps":0,"marketStatus":"Pre-Mkt","change":0,"latestTime":"10-28 05:58:58 EDT","open":24.975,"high":24.975,"low":24.975,"amount":2247.997,"amplitude":0,"askPrice":39.71,"askSize":100,"bidPrice":10,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1761658200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":24.975,"sharesOutstanding":2225000,"nav":24.945964,"aum":55504850,"dividendRate":0.015103,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.975,"preClose":24.975,"latestTime":"16:04 EDT","volume":3,"amount":74.94,"timestamp":1761595450723},"volumeRatio":1.7786505022909018},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABI\",,,,,undefined,":{"symbol":"ABI","floatShares":2225000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.7786505022909018,"shares":2225000,"dividePrice":0.3772,"high":24.975,"amplitude":0,"preClose":24.975,"low":24.975,"week52Low":24.885,"pbRate":"--","week52High":25.27,"institutionHeld":0,"latestPrice":24.975,"committee":0.333333,"eps":0,"divideRate":0.015103,"volume":90,"delay":0,"ttmEps":0,"open":24.975,"prevYearClose":25.08,"prevWeekClose":24.975,"prevMonthClose":25.035,"prevQuarterClose":25.035,"fiveDayClose":24.98,"twentyDayClose":25.005,"sixtyDayClose":25.13},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABI\",params:#limit:5,,,undefined,":[{"date":"2025-10-09","symbol":"ABI","amount":0.146893,"announcedDate":"2025-10-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-09","defaultRemindTime":1760016600000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-10","payableDate":"2025-10-09","currency":"USD","dateTimestamp":1759982400000,"payDate":"2025-10-10"},{"date":"2025-09-08","symbol":"ABI","amount":0.132826,"announcedDate":"2025-09-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-08","defaultRemindTime":1757338200000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-09","payableDate":"2025-09-08","currency":"USD","dateTimestamp":1757304000000,"payDate":"2025-09-09"},{"date":"2025-08-06","symbol":"ABI","amount":0.083425,"announcedDate":"2025-08-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-06","defaultRemindTime":1754487000000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-07","payableDate":"2025-08-06","currency":"USD","dateTimestamp":1754452800000,"payDate":"2025-08-07"},{"date":"2025-07-10","symbol":"ABI","amount":0.01517,"announcedDate":"2025-07-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-10","defaultRemindTime":1752154200000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-11","payableDate":"2025-07-10","currency":"USD","dateTimestamp":1752120000000,"payDate":"2025-07-11"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABI\",market:\"US\",,,undefined,":[{"executeDate":"2025-07-10","recordDate":"2025-07-10","paymentDate":"2025-07-11","value":0.01517,"currency":"USD"},{"executeDate":"2025-08-06","recordDate":"2025-08-06","paymentDate":"2025-08-07","value":0.083425,"currency":"USD"},{"executeDate":"2025-09-08","recordDate":"2025-09-08","paymentDate":"2025-09-09","value":0.132826,"currency":"USD"},{"executeDate":"2025-10-09","recordDate":"2025-10-09","paymentDate":"2025-10-10","value":0.146893,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABI\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2578621821","title":"Assembly Biosciences’ ABI-6250 Study: A Potential Game-Changer in Hepatitis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2578621821","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578621821?lang=en_us&edition=fundamental","pubTime":"2025-10-28 01:17","pubTimestamp":1761585436,"startTime":"0","endTime":"0","summary":"Assembly Biosciences Inc (($ASMB)) announced an update on their ongoing clinical study. Assembly Biosciences Inc. is conducting a Phase 1a clinical...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/assembly-biosciences-abi-6250-study-a-potential-game-changer-in-hepatitis-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/assembly-biosciences-abi-6250-study-a-potential-game-changer-in-hepatitis-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABI","BK4139","ASMB"],"gpt_icon":0},{"id":"2577315288","title":"AIA: \"Softness persists at architecture firms\" in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2577315288","media":"Calculated Risk","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577315288?lang=en_us&edition=fundamental","pubTime":"2025-10-22 15:46","pubTimestamp":1761119160,"startTime":"0","endTime":"0","summary":"From the AIA: ABI September 2025: Weakness persists at architecture firmsThe AIA/Deltek Architecture Billings Index  score of 43.3 for the month is the softest reading since April and represents an increase in the share of firms reporting a decrease from August. In addition, inquiries into new projects remained flat for the second consecutive month, following growth over the summer, and the value of newly signed design contracts decreased for the 19th consecutive month. All of these indicators mean that the soft conditions that many architecture firms have been experiencing since late 2022 are likely to persist for the foreseeable future.The ABI serves as a leading economic indicator that leads nonresidential construction activity by approximately 9-12 months.emphasis added Northeast ; Midwest ; South ; West . This index usually leads CRE investment by 9 to 12 months, so this index suggests a slowdown in CRE investment throughout","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"calculatedriskblog_highlight","url":"https://www.calculatedriskblog.com/2025/10/aia-softness-persists-at-architecture.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.calculatedriskblog.com/2025/10/aia-softness-persists-at-architecture.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"calculatedriskblog_highlight","symbols":["BK4087","CRE","AIA","ABI"],"gpt_icon":0},{"id":"2575296609","title":"Promising Phase 1b Results for ABI-5366 Drive Buy Rating for Assembly Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2575296609","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575296609?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:15","pubTimestamp":1760436925,"startTime":"0","endTime":"0","summary":"Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Assembly Biosciences and keeping the price target at $50.00. Patrick Trucc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-1b-results-for-abi-5366-drive-buy-rating-for-assembly-biosciences-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-1b-results-for-abi-5366-drive-buy-rating-for-assembly-biosciences-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABI","ASMB"],"gpt_icon":0},{"id":"2574017554","title":"Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2574017554","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574017554?lang=en_us&edition=fundamental","pubTime":"2025-10-10 20:00","pubTimestamp":1760097600,"startTime":"0","endTime":"0","summary":"– Late-breaking oral presentation highlights interim Phase 1b data reported earlier this year for two cohorts in participants with recurrent genital herpes – – Statistically significant reductions in ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/10/3164831/16259/en/Assembly-Biosciences-Presents-Interim-Phase-1b-Data-for-HSV-Helicase-Primase-Inhibitor-Candidate-ABI-5366-at-the-38th-Congress-of-the-International-Union-Against-Sexually-Transmitt.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ASMB","BK4139","HDV","ABI","BK4588"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ABI\",params:#limit:6,delay:false,,,undefined,":[]}}